Lesson plan
clonitazene
Clonitazene is an opioid analgesic of approximately three times the potency of morphine. It is in the nitazene family of benzimidazoles related to etonitazene, an opioid of significantly higher potency. Clonitazene is not currently marketed. It is a controlled substance; in the United States it is a Schedule I Narcotic controlled substance with a DEA ACSCN of 9612 and an established manufacturing quota of 25 grams for 2022.
Article summary
Clonitazene is an opioid analgesic of approximately three times the potency of morphine. It is in the nitazene family of benzimidazoles related to etonitazene, an opioid of significantly higher potency. Clonitazene is not currently marketed. It is a controlled substance; in the United States it is a Schedule I Narcotic controlled substance with a DEA ACSCN of 9612 and an established manufacturing quota of 25 grams for 2022.
Key claims
- date of establishment: 2022 — source: Wikipedia, revision 1373293148, retrieved 2026-10-20 · confidence 0.95
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- The record states that the date of establishment is "2022". What evidence would count against this claim?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
- Wikipedia, “clonitazene”, revision 1373293148, retrieved 2026-10-20 https://en.wikipedia.org/w/index.php?oldid=1373293148
Key claims and bibliography are generated from the same tracked claims and sources as the article page.